Assessment of Hepatocellular Carcinoma Response to Locoregional Therapy:  Imaging Criteria, Algorithms, and Emerging Radiologic Tools

Magdy Mohamed Alfawal, Hossam Eldin Mansour Abdelrahman, Ahmed Abd-Elazim Ismail,  Finan Abdulrhman Shabrawy Abbas

Assessment of Hepatocellular Carcinoma Response to Locoregional Therapy: Imaging Criteria, Algorithms, and Emerging Radiologic Tools

Authors

Magdy Mohamed Alfawal, Hossam Eldin Mansour Abdelrahman, Ahmed Abd-Elazim Ismail, Finan Abdulrhman Shabrawy Abbas

Keywords:

Hepatocellular Carcinoma, Locoregional Therapy, Imaging Criteria

Abstract

Hepatocellular carcinoma (HCC) is the most prevalent primary liver malignancy and a leading cause ofcancer-related mortality globally. Locoregional therapies (LRTs) such as radiofrequency ablation (RFA), microwave ablation (MWA),

References

Samant H, Amiri HS, Zibari GB. Addressing the worldwide hepatocellular carcinoma: epidemiology, prevention and management. J Gastrointest Oncol. 2021;12(Suppl 2):S361S373. doi:10.21037/jgo.2020.02.08

Lencioni R. Loco-regional treatment of hepatocellular carcinoma. Hepatology. 2010;52(2):762-773

Downloads

Published

2024-06-15

How to Cite

Magdy Mohamed Alfawal, Hossam Eldin Mansour Abdelrahman, Ahmed Abd-Elazim Ismail, Finan Abdulrhman Shabrawy Abbas. (2024). Assessment of Hepatocellular Carcinoma Response to Locoregional Therapy: Imaging Criteria, Algorithms, and Emerging Radiologic Tools . Journal of Computational Analysis and Applications (JoCAAA), 33(06), 1978–1990. Retrieved from https://www.eudoxuspress.com/index.php/pub/article/view/2826